BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 20675036)

  • 1. Perioperative cesarean delivery morbidity among HIV-infected women under highly active antiretroviral treatment: a case-control study.
    Maiques V; Garcia-Tejedor A; Diago V; Molina JM; Borras D; Perales-Puchalt A; Perales A
    Eur J Obstet Gynecol Reprod Biol; 2010 Nov; 153(1):27-31. PubMed ID: 20675036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mode of delivery of HIV-infected women: a retrospective study of 358 pregnancies followed in the same hospital between 2000 and 2004].
    Rodrigues A; Faucher P; Batallan A; Allal L; Legac S; Matheron S; Madelenat P
    Gynecol Obstet Fertil; 2006 Apr; 34(4):304-11. PubMed ID: 16574463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postpartum contraceptive preferences of HIV-infected women in the era of highly active antiretroviral therapy (HAART) and scheduled cesarean deliveries.
    Tuuli MG; Duong TH; Yost NP; Ellis J; Burke CV; Basanta-Henry PL; Lindsay M
    Contraception; 2011 Aug; 84(2):150-4. PubMed ID: 21757056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased peri- and post-elective cesarean section morbidity in women infected with human immunodeficiency virus-1: a case-controlled multicenter study.
    Lapaire O; Irion O; Koch-Holch A; Holzgreve W; Rudin C; Hoesli I;
    Arch Gynecol Obstet; 2006 Jun; 274(3):165-9. PubMed ID: 16715290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-cesarean section morbidity in HIV-positive women.
    Maiques-Montesinos V; Cervera-Sanchez J; Bellver-Pradas J; Abad-Carrascosa A; Serra-Serra V
    Acta Obstet Gynecol Scand; 1999 Oct; 78(9):789-92. PubMed ID: 10535342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-operative complications after caesarean section in HIV-infected women.
    Ferrero S; Bentivoglio G
    Arch Gynecol Obstet; 2003 Oct; 268(4):268-73. PubMed ID: 14504867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Second pregnancies in HIV-1-infected women. A prospective monocentric study].
    Monpoux F; Delotte J; Galiba E; de Smet S; Durant J; Boutté P; Bongain A
    Gynecol Obstet Fertil; 2008 Apr; 36(4):379-85. PubMed ID: 18375168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initiation of highly active antiretroviral therapy among pregnant women in Cape Town, South Africa.
    Stinson K; Boulle A; Coetzee D; Abrams EJ; Myer L
    Trop Med Int Health; 2010 Jul; 15(7):825-32. PubMed ID: 20497405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of highly active antiretroviral treatment (HAART) on risk factors for vertical HIV transmission.
    Garcia-Tejedor A; Maiques V; Perales A; Lopez-Aldeguer J
    Acta Obstet Gynecol Scand; 2009; 88(8):882-7. PubMed ID: 19557554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Highly active antiretroviral therapy (HAART) in HIV-positive pregnant women in the Netherlands, 1997-2003: safe, effective and with few side effects].
    Tempelman C; Timmermans S; Godfried MH; Dieleman JP; Boer K; van der Ende ME
    Ned Tijdschr Geneeskd; 2004 Oct; 148(41):2021-5. PubMed ID: 15553999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy.
    European Collaborative Study
    Clin Infect Dis; 2005 Feb; 40(3):458-65. PubMed ID: 15668871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perioperative morbidity and mortality among human immunodeficiency virus infected women undergoing cesarean delivery.
    Louis J; Landon MB; Gersnoviez RJ; Leveno KJ; Spong CY; Rouse DJ; Moawad AH; Varner MW; Caritis SN; Harper M; Wapner RJ; Miodovnik M; Carpenter M; Peaceman AM; O'Sullivan MJ; Sibai BM; Langer O; Thorp JM; Ramin SM; Mercer BM;
    Obstet Gynecol; 2007 Aug; 110(2 Pt 1):385-90. PubMed ID: 17666615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complications after caesarean section in HIV-1-infected women not taking antiretroviral treatment.
    Grubert TA; Reindell D; Kästner R; Lutz-Friedrich R; Belohradsky BH; Dathe O
    Lancet; 1999 Nov; 354(9190):1612-3. PubMed ID: 10560681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.
    Ekouevi DK; Coffie PA; Becquet R; Tonwe-Gold B; Horo A; Thiebaut R; Leroy V; Blanche S; Dabis F; Abrams EJ
    AIDS; 2008 Sep; 22(14):1815-20. PubMed ID: 18753864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [HIV and pregnancy].
    Petry KU
    MMW Fortschr Med; 2005 Apr; 147 Spec No 1():63-5. PubMed ID: 16385880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human immunodeficiency virus and pregnancy.
    Reshi P; Lone IM
    Arch Gynecol Obstet; 2010 May; 281(5):781-92. PubMed ID: 20035338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased rates of preterm delivery are associated with the initiation of highly active antiretrovial therapy during pregnancy: a single-center cohort study.
    Martin F; Taylor GP
    J Infect Dis; 2007 Aug; 196(4):558-61. PubMed ID: 17624841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cesarean delivery for HIV-infected women: recommendations and controversies.
    Jamieson DJ; Read JS; Kourtis AP; Durant TM; Lampe MA; Dominguez KL
    Am J Obstet Gynecol; 2007 Sep; 197(3 Suppl):S96-100. PubMed ID: 17825656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of HIV-1 infected pregnant women].
    Nellen JF; Godfried MH; Kreijenbroek ME; Scherpbier HJ; Prins JM; Boer K
    Ned Tijdschr Geneeskd; 2004 Oct; 148(41):2005-8. PubMed ID: 15553994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of pregnancy in HIV-positive women planned for vaginal delivery under effective antiretroviral therapy.
    Islam S; Oon V; Thomas P
    J Obstet Gynaecol; 2010 Jan; 30(1):38-40. PubMed ID: 20121502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.